Blogs

Mais Recentes

• Biosensors Market Share, Size, Growth and Trends by 2035

  by Sofia Smith 23 de março de 2023
  Biosensors Market focused on drug discovery and development is projected to grow at an annualized rate of 9% during the period 2023-2035   In recent years, the use of biosensors in drug discovery has been on the rise, driven by several technological advancements and the growing demand for ine...

• The mRNA therapeutics and vaccines segment

  by Sofia Smith 28 de dezembro de 2022
  Post the onset of the COVID-19 pandemic, mRNA therapeutics and vaccines have garnered significant attention as they have evolved as a revolutionary novel drug class for the treatment of COVID-19, as well as several other diseases, such as infectious diseases, oncological disorders, genetic disorders...

• Live biotherapeutic products and microbiome manufacturing

  by Sofia Smith 26 de dezembro de 2022
  In recent years, the potential of microbiome-based leads for the treatment of a myriad disease indications has been widely recognized, presenting lucrative opportunities for drug developers and contract manufacturers alike.   London Roots Analysis has announced the addition of the “Liv...

• RNA Extraction and Purification Kits

  by Sofia Smith 15 de dezembro de 2022
  Amongst the total players involved in the development of RNA extraction and purification kits and reagents, majority of the players engaged in the development of RNA extraction and purification kits were established between 1981-2000.   During our research, we were able to identify more than ...

• RNAi THERAPY

  by Sofia Smith 14 de dezembro de 2022
    Owing to their vast potential in controlling disease-associated gene expression, RNAi therapeutics have emerged as a key segment of the market; several big pharma players have undertaken RNAi focused initiatives.   In addition to effective gene silencing, these candidates can be deplo...

• The rare kidney disorders market

  by Sofia Smith 12 de dezembro de 2022
  Considering the rising unmet need associated with rare kidney disorders and the growing adoption of available treatment options, industry stakeholders have made significant investments to enable the development of novel drug candidates targeting this set of rare diseases   London Roots Analy...

• The at-home self-testing kits market

  by Sofia Smith 8 de dezembro de 2022
  Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes.   London Roots Analysis h...

• The at-home self-testing kits market is projected to grow at a

  by Sofia Smith 8 de dezembro de 2022
  Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes.

• The pharmaceutical industry is presently experiencing a promine

  by Sofia Smith 7 de dezembro de 2022
  Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug.   Bioavailability refers to the proportion of a drug that reaches systemic ...

• The SARM1 targeting therapeutics market is projected to grow at

  by Sofia Smith 6 de dezembro de 2022
  SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share   Roots Analysis has announced the addition of &l...

• The cell and gene therapy CROs market is anticipated to grow at

  by Sofia Smith 5 de dezembro de 2022
  Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years.   Roots Analysis has announced the addition of Cell and ...

• The mRNA therapeutics and vaccines segment is anticipated to re

  by Sofia Smith 2 de dezembro de 2022
  Post the onset of the COVID-19 pandemic, mRNA therapeutics and vaccines have garnered significant attention as they have evolved as a revolutionary novel drug class for the treatment of COVID-19, as well as several other diseases, such as infectious diseases, oncological disorders, genetic disorders...

• Aptamers Market by Industry Trends and Global Forecasts, 2022-2

  by Sofia Smith 2 de setembro de 2022
  THE RISING REALM AMONGST STAKEHOLDERS IN PURSUIT OF ALTERNATIVE THERAPIES TO ANTIBODIES THERAPIES Aptamers have gained a lot of momentum in the past decade. It is worth highlighting that in 2005, Macugen became the first and the only USFDA approved aptamer drug for treating age-related macular deg...